RVTY

Revvity Inc

• Dow Jones·1d ago

  Revvity Is Maintained at Neutral by JP Morgan

• Dow Jones·1d ago

  Revvity Price Target Cut to $96.00/Share From $105.00 by JP Morgan

• Benzinga·1d ago

  JP Morgan Maintains Neutral on Revvity, Lowers Price Target to $96

• Simply Wall St·4d ago

  Revvity Vote On Special Meetings And Stock Retention Meets Valuation Gap

• TipRanks·03/26 11:15

  Revvity upgraded to Hold from Sell at Nephron Research

• Simply Wall St·03/22 09:09

  Reassessing Revvity (RVTY) Valuation After Strong Q4 Results And Weaker Guidance Versus Peers

• Simply Wall St·03/20 12:09

  How Investors May Respond To Revvity (RVTY) Cautious Outlook And Pushback On Executive Stock-Retention Rules

• TipRanks·03/13 14:20

  Analysts Have Conflicting Sentiments on These Healthcare Companies: Revvity (RVTY) and Candel Therapeutics (CADL)

• Dow Jones·03/12 20:36

  Revvity Inc. Stock Sheds 5.4%, Underperforms Peers

• Dow Jones·03/06 21:34

  Revvity Inc. Stock Falls 5.4%, Underperforms Peers

• NASDAQ·03/06 19:35

  Friday Sector Laggards: Healthcare, Financial

• Simply Wall St·03/06 09:35

  The Bull Case For Revvity (RVTY) Could Change Following Cautious 2026 Outlook And Capital Allocation Scrutiny

• NASDAQ·03/04 16:30

  Why Is Revvity (RVTY) Down 5.1% Since Last Earnings Report?

• Simply Wall St·03/03 08:19

  Reassessing Revvity (RVTY) Valuation After Prolonged Share Price Weakness

• Simply Wall St·03/01 01:23

  Revvity (RVTY) Valuation Check After Recent Share Price Weakness